Related Experiment Video

Updated: Aug 11, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Human parvovirus B19: a new emerging pathogen of inflammatory cardiomyopathy

C-T Bock1, K Klingel, S Aberle

  • 1Department of Molecular Pathology, Institute of Pathology, University Hospital of Tuebingen, Tuebingen, Germany. thomas.bock@med.uni-tuebingen.de

Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health
|December 1, 2005
PubMed

Insights

Human parvovirus B19 (PVB19) is emerging as a cause of inflammatory cardiomyopathy in adults. Research suggests PVB19 infects heart cells, potentially leading to cardiac dysfunction and inflammation.

Area of Science:

  • Virology
  • Cardiology
  • Pathology

Background:

  • Human parvovirus B19 (PVB19) is the only known pathogenic human parvovirus.
  • Enteroviruses are traditionally linked to inflammatory cardiomyopathy, but PVB19 is an emerging cause.
  • Previous studies suggest PVB19 association with pediatric and adult inflammatory cardiac disease, but its role in adult inflammatory cardiomyopathy remains unclear.

Purpose of the Study:

  • To investigate the potential role of human parvovirus B19 (PVB19) in the development of inflammatory cardiomyopathy in adult patients.

Main Methods:

  • Utilized molecular biology techniques, including in situ hybridization (ISH) and polymerase chain reaction (PCR), to detect PVB19.
  • Examined cardiac tissue for evidence of PVB19 infection and associated pathological changes.

Main Results:

  • Evidence suggests PVB19 infects endothelial cells in small intracardiac blood vessels.
  • PVB19 infection may lead to endothelial dysfunction and impaired myocardial microcirculation.
  • Inflammatory cell infiltration into the myocardium is observed in PVB19-associated cases.

Conclusions:

  • Human parvovirus B19 (PVB19) is implicated as a potential etiological agent in adult inflammatory cardiomyopathy.
  • PVB19-associated cardiomyopathy involves cardiac endothelial cell infection, microcirculation impairment, and myocardial inflammation.

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Microdissection and Immunofluorescence Staining of Myocardial Sleeves in Murine Pulmonary Veins08:52

Microdissection and Immunofluorescence Staining of Myocardial Sleeves in Murine Pulmonary Veins

Published on: November 21, 2023

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...